• 1 January 1980
    • journal article
    • research article
    • Vol. 40  (11) , 4178-4182
Abstract
Approximately 30-40% of human leukemic cell lines are completely deficient in the purine catabolic enzyme 5''-methylthioadenosine phosphorylase. Using two 5''-methylthioadenosine phosphorylase-negative leukemias, the synthesis and biological effects of 5''-methylthioadenosine (MTA) in intact tumor cells was measured. Malignant cells lacking this enzyme, unlike enzyme-positive cells, excreted MTA into the culture medium at a rate of 0.58-0.70 nmol/h per mg protein. The production of the nucleoside was inhibited effectively by nontoxic concentrations of methylglyoxal bis(guanylhydrazone), a putrescine-dependent S-adenosylmethionine decarboxylase inhibitor, and also by spermidine and spermine but was enhanced by putrescine. In a reciprocal fashion, MTA at low concentrations progressively increased the synthesis and concentration of putrescine but suppressed spermine production. The unique alterations in polyamine metabolism induced by elevated MTA levels could offer a selective growth advantage to the 5''-methylthioadenosine phosphorylase-deficient cells and thus may be related to the high frequency of this enzyme deficiency among human leukemic cell lines.

This publication has 19 references indexed in Scilit: